Medical therapies for the management of cardiomyopathy and chronic congestive heart failure

被引：0

作者：

Meyers D. ^{[1
]}

机构：

[1] Department of Cardiology, Division of Internal Medicine, University of Texas Houston, Houston, TX, 77030, 6431 Fannin Street

来源：

Current Cardiovascular Risk Reports | 2009年 / 3卷 / 5期

关键词：

Palliative Care; Chronic Heart Failure; Cardiac Resynchronization Therapy; Left Ventricular Assist Device; Acute Decompensated Heart Failure;

D O I：

10.1007/s12170-009-0047-2

中图分类号：

学科分类号：

摘要：

Medical therapy for congestive heart failure has rapidly evolved over the past decade to include a spectrum of therapies that extend well beyond the traditional pharmaceutical-based strategies of the past. These therapies include multidisciplinary care, transplantation, device-based therapies with resynchronization, defibrillator therapy, and an expanding array of circulatory support devices designed for patients with both acute and chronic heart failure. It is critical that clinicians develop an understanding of the illness trajectory associated with heart failure progression in order to choose the most appropriate management strategies for each stage of the disease. © 2009 Current Medicine Group, LLC.

引用

页码：315 / 322

页数：7

共 36 条

[1]

Rosamond W., Flegal K., Furie K., Et al., Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation, 117, (2008)

[2]

Cohn J.N., Prognosis in congestive heart failure, J Card Fail, 2, (1996)

[3]

Fonarow G.C., Corday E., Overview of acutely decompensated congestive heart failure (ADHF): a report from the ADHERE registry, Heart Fail Rev, 9, pp. 179-185, (2004)

[4]

Aurora P., Edwards L.B., Christie J., Et al., Registry of the International Society for Heart and Lung Transplantation: eleventh official pediatric lung and heart/lung transplantation report-2008, J Heart Lung Transplant, 27, pp. 978-983, (2008)

[5]

Costanzo M.R., Mills R.M., Wynne J., Characteristics of "Stage D" heart failure: insights from the Acute Decompensated Heart Failure National Registry Longitudinal Module (ADHERE LM), Am Heart J, 155, pp. 339-347, (2008)

[6]

Yancy C.W., Lopatin M., Stevenson L.W., Et al., Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database, J Am Coll Cardiol, 47, pp. 76-84, (2006)

[7]

Cleland J.G., Swedberg K., Cohen-Solal A., Et al., The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for Health Economics University of York, Eur J Heart Fail, 2, pp. 123-132, (2000)

[8]

Cleland J.G., Swedberg K., Follath F., Et al., The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis, Eur Heart J, 24, pp. 442-463, (2003)

[9]

Komajda M., Follath F., Swedberg K., Et al., The EuroHeart Failure Survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment, Eur Heart J, 24, pp. 464-474, (2003)

[10]

Adams Jr. K.F., Fonarow G.C., Emerman C.L., LeJemtel T.H., Et al., Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE), Am Heart J, 149, pp. 209-216, (2005)

← 1 2 3 4 →